Clinical Trials
- Hepatitis, HIV/AIDS, Immune System, Infectious Disease
Screening In Anticipation of Future Research
- Ages2 years - 17 years
- GenderBoth
- Endocrine System, Genetics
test
- Ages18 years - 60 years
- GenderBoth
- Hepatitis, Liver
Digoxin In Alcohol Associated Hepatitis
- Ages21 years - 65 years
- GenderBoth
- Liver
Safety, Tolerability, and Efficacy of Cilofexor in Non-Cirrhotic Adults With Primary Sclerosing Cholangitis (PRIMIS)
- Ages18 years - 75 years
- GenderBoth
- Liver, Vision/Eye, Brain, Spinal Cord & Nervous System
Wilson Disease Registry
- GenderBoth
- Phase 1 Cancers
test
- Immune System
Seladelpar in Subjects With Primary Biliary Cholangitis (PBC)
- Ages18 years - 75 years
- GenderBoth
- Leukemia
The PRIME Trial: PARP Inhibition in IDH Mutant Effectiveness Trial. A Phase II Study of Olaparib in Isocitrate Dehydrogenase (IDH) Mutant Relapsed/Refractory Acute Myeloid Leukemia and Myelodysplastic Syndrome
- Prostate Cancer
Phase III Trial of Docetaxel vs. Docetaxel and Radium-223 for Metastatic Castration-Resistant Prostate Cancer (mCRPC)
- Ages18 years and older
- GenderMale only
- Leukemia
Phase II Study of Adding the Anti-PD-1 Pembrolizumab to Tyrosine Kinase Inhibitors in Patients With Chronic Myeloid Leukemia and Persistently Detectable Minimal Residual Disease